Information for Alliance Members

David S. Block. M.D., M.B.A.
Founder and CEO, Ruxton Pharmaceuticals, Inc.

David S. Bredt, M.D., Ph.D.
Vice President, Integrative Biology
Lilly Research Laboratories, Corporate Center

Samuel Broder, M.D.
Chief Medical Officer
Celera Genomics

James Campbell, M.D.
Scientific Advisor
Interwest Partners
Professor, Neurosurgery
Johns Hopkins University School of Medicine

C. Thomas Caskey, MD, FACP
Director-/CEO-Elect & Chief Operating Officer
Brown Foundation Institute of Molecular Medicine
The University of Texas Health Science Center at Houston

Mr. Joseph A. Ciffolillo
(retired Medical Device Executive)

Kenneth Fasman, Ph.D.
Director, Drug Development Strategy and Performance
AstraZeneca PLC

Philip Goelet, Ph.D.
Red Abbey

Ms. Elizabeth Good
Managing Director
State of Maryland Venture Fund

Mr. Steve Gorlin
Principal
Gorlin Companies

Leroy E. Hood, MD, PhD
President
Institute for Systems Biology

Mr. Robert S. King
Managing Director - Investment Banking
MAXIM GROUP LLC

Chris Kroeger, M.D., M.B.A.
Principal
Aurora Funds, Inc.

Robert D. Mashal, M.D.
President & CEO
Alinea Pharmaceuticals

Mr. Troy Moore
Chief Technology Offcier
Open Biosystems

Mr. Richard Newman
Vice President Advanced Solutions
Welch Allyn, Inc.

James Niedel, MD, PhD
Managing Director
New Leaf Venture Partners, LLC

Stephen N. Oesterle, MD
Senior VP for Medicine and Technology
Medtronic, Inc.

Christopher Shen, M.D., M.B.A.
Principal
NEA

Irving Sherman, MD
(retired neurosurgeon)

Michael I. Sherman, Ph.D.
Venture Partner
Elm Street Ventures

Craig R. Smith, MD
(retired) former Chairman, President, & CEO
Guilford Pharmaceuticals

Joseph M. Smith, MD, PhD, FACC
Senior Vice President
Chief Medical Officer
Cardiac Rhythm Management
Guidant Corporation